Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-31
1999-01-05
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514424, 514634, 546291, 548543, 564237, A61K 3144, C07D21363, C07D21136, C07C27922
Patent
active
058563440
ABSTRACT:
Benzoylguanidines of the formula I ##STR1## in which R(1) to R(6) have the meanings stated in the claims, are antiarrhythmic pharmaceuticals which have excellent activity and a cardioprotective component and are highly suitable for the prophylaxis of infarcts and the treatment of infarcts, and for the treatment of angina pectoris, in which case they also preventively inhibit or greatly reduce the pathophysiological processes in the development of ischemia-induced damage, especially in the triggering of ischemia-induced cardiac arrhythmias.
REFERENCES:
patent: 3780027 (1973-12-01), Cargoe et al.
patent: 5091394 (1992-02-01), Englert et al.
patent: 5140039 (1992-08-01), DeBernardis et al.
patent: 5185364 (1993-02-01), DeBernardis et al.
patent: 5292755 (1994-03-01), Englert et al.
patent: 5364868 (1994-11-01), Englert et al.
patent: 5373024 (1994-12-01), Lang et al.
patent: 5395826 (1995-03-01), Naumann et al.
patent: 5416094 (1995-05-01), Lal et al.
patent: 5498617 (1996-03-01), Naumann et al.
patent: 5516805 (1996-05-01), Lang et al.
patent: 5547953 (1996-08-01), Weichert et al.
patent: 5559153 (1996-09-01), Schwark et al.
patent: 5567734 (1996-10-01), Schwark et al.
patent: 5571842 (1996-11-01), Kleemann et al.
patent: 5591754 (1997-01-01), Lang et al.
Chemical Abstracts, vol. 125(7) abst. No. 86, 331-t, pub. Aug. 12, 1996.
Chemical Abstracts, vol. 125(9), abst. No. 114,323n, pub. Aug. 26, 1996.
Eur. Heart of J. 9(suppl. 1):25 and 167 (1988) book of abstracts.
Schmid, Andreas et al. Biochemical and Biophysical Research Comm. 112-117 (1992).
Scholz, Wolfgang et al. Cardiovascular Res. (1995) 29(2):260-8.
Rosskopf, Dieter et al. Cellular Physiology Biochem (1995), (5)4, 269-275.
Scholz, Wolfgang et al. Basic Research Cardiology (1993), 88(5), 443-55.
Sack, Stefan et al. J. Cardiovasc. Pharmacol. (1994)23(1), 72-78.
Kranzhofer, Roger et al. Circ. Res.,(1993), 73(2), 264-8.
Scholz, Wolfgang et al. Br. J. Pharmacol. (1993), 109(2), 562-8.
Scholz, Wolfgang et al. J. Mol. Cell. Cardiol. (1992), 24(7), 731-39.
Scholz, Wolfgang et al. Cardiovascular Research. (Feb.,1995) vol. 29(2), 184-8.
Biological Chemistry Hoppe-Seyler (1991), vol. 372, No. 9, p. 750.
Mitsuka, Masayuki et al. Circulation Research (1993), vol. 73(2):269-275.
Duff, Henry J. et al., Circulation, 79(6), 1257-63 (1989).
Dixon, Robert P. et al., J. Am Chem Soc. (1992) 114 (1), 365-6.
Albus Udo
Brendel Joachim
Kleemann Heinz-Werner
Lang Hans Jochen
Scholz Wolfgang
Hoechst Aktiengesellschaft
Rotman Alan L.
LandOfFree
Sulfonylamino-substituted benzoylguanidines, a process for their does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonylamino-substituted benzoylguanidines, a process for their, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylamino-substituted benzoylguanidines, a process for their will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862644